mazindol has been researched along with Albers-Schoenberg Disease in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batchelor, PE | 1 |
| Porritt, MJ | 1 |
| Nilsson, SK | 1 |
| Bertoncello, I | 1 |
| Donnan, GA | 1 |
| Howells, DW | 1 |
1 other study available for mazindol and Albers-Schoenberg Disease
| Article | Year |
|---|---|
Periwound dopaminergic sprouting is dependent on numbers of wound macrophages.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain Injuries; Carboxylesterase; Carboxylic Ester Hydrolases | 2002 |